Intracoronary administration of paclitaxel nanoparticles during percutaneous coronary intervention for intimal hyperplasia suppression after bare-metal stent implantation
Chamié D, Abizaid A, Costa J, Feres F, Gama G, Belzares O, Staico R, Mattos L, Costa R, Siqueira D, Abizaid A, Chaves Á, Centemero M, Tanajura L, Sousa A, Sousa J. Intracoronary administration of paclitaxel nanoparticles during percutaneous coronary intervention for intimal hyperplasia suppression after bare-metal stent implantation. Journal Of Transcatheter Interventions 2010, 18: 140-150. DOI: 10.1590/s2179-83972010000200007.Peer-Reviewed Original ResearchBare-metal stent implantationPercutaneous coronary interventionStent implantationABI-007Neointimal hyperplasiaFollow-upCoronary interventionIntravascular ultrasoundAdverse toxic eventsSuppression of neointimal hyperplasiaAlbumin-bound paclitaxelLeft anterior descending arteryNeointimal volume obstructionStent implantation methodAnterior descending arteryTissue formationLong-term safetySignificant vascular remodelingSynthetic polymersSix-month follow-upIntravascular ultrasound assessmentDecreased neointimal hyperplasiaPaclitaxel nanoparticlesBare-metal stentsDrug-eluting stents
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply